128 related articles for article (PubMed ID: 10437750)
1. Lipid intolerance in neonates receiving dexamethasone for bronchopulmonary dysplasia.
Amin SB; Sinkin RA; McDermott MP; Kendig JW
Arch Pediatr Adolesc Med; 1999 Aug; 153(8):795-800. PubMed ID: 10437750
[TBL] [Abstract][Full Text] [Related]
2. An Evaluation to Establish the Acceptable Serum Triglyceride Levels in Neonates Receiving Intravenous Fat Emulsion Infusion in a Multicenter Retrospective Study.
Chan B; Lian A; Baer V; Robinson M; Ou Z; Presson AP; Zinkhan EK
Am J Perinatol; 2021 Aug; 38(S 01):e92-e101. PubMed ID: 32120418
[TBL] [Abstract][Full Text] [Related]
3. Hypertriglyceridaemia in extremely preterm infants receiving parenteral lipid emulsions.
Sinclair R; Schindler T; Lui K; Bolisetty S
BMC Pediatr; 2018 Nov; 18(1):348. PubMed ID: 30404604
[TBL] [Abstract][Full Text] [Related]
4. Hypertriglyceridemia in extremely low birth weight infants receiving lipid emulsions.
Holtrop P; Swails T; Riggs T
J Neonatal Perinatal Med; 2015; 8(2):133-6. PubMed ID: 26410437
[TBL] [Abstract][Full Text] [Related]
5. Effect of dexamethasone therapy on serum vitamin E concentrations in premature infants with bronchopulmonary dysplasia.
Amin SB; Laroia N; Sinkin RA; Kendig JW
J Perinatol; 2003 Oct; 23(7):552-5. PubMed ID: 14566351
[TBL] [Abstract][Full Text] [Related]
6. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.
Koopmans SJ; Kushwaha RS; DeFronzo RA
Metabolism; 1999 Mar; 48(3):330-7. PubMed ID: 10094109
[TBL] [Abstract][Full Text] [Related]
7. Free fatty acid and triglyceride levels in neonates receiving triple mix hyperalimentation.
Neal PR; Erickson PA; Yu PL; Lemons JA
J Perinatol; 1988; 8(3):199-202. PubMed ID: 3147321
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of dexamethasone in premature neonates.
Lugo RA; Nahata MC; Menke JA; McClead RE
Eur J Clin Pharmacol; 1996; 49(6):477-83. PubMed ID: 8706773
[TBL] [Abstract][Full Text] [Related]
9. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
[TBL] [Abstract][Full Text] [Related]
10. Total parenteral nutrition with intralipid in premature infants receiving TPN with heparin: effect on plasma lipolytic enzymes, lipids, and glucose.
Berkow SE; Spear ML; Stahl GE; Gutman A; Polin RA; Pereira GR; Olivecrona T; Hamosh P; Hamosh M
J Pediatr Gastroenterol Nutr; 1987; 6(4):581-8. PubMed ID: 3123635
[TBL] [Abstract][Full Text] [Related]
11. Lipid intolerance in newborns is associated with hepatic dysfunction but not infection.
Toce SS; Keenan WJ
Arch Pediatr Adolesc Med; 1995 Nov; 149(11):1249-53. PubMed ID: 7581757
[TBL] [Abstract][Full Text] [Related]
12. Safflower oil emulsion administration during parenteral nutrition in the preterm infant. 2. Effect on triglyceride and free fatty acid levels.
Cooke RJ; Buis M; Zee P; Yeh YY
J Pediatr Gastroenterol Nutr; 1985 Oct; 4(5):804-7. PubMed ID: 3930689
[TBL] [Abstract][Full Text] [Related]
13. Cholestasis, bronchopulmonary dysplasia, and lipid profile in preterm infants receiving MCT/ω-3-PUFA-containing or soybean-based lipid emulsions.
Skouroliakou M; Konstantinou D; Agakidis C; Delikou N; Koutri K; Antoniadi M; Karagiozoglou-Lampoudi T
Nutr Clin Pract; 2012 Dec; 27(6):817-24. PubMed ID: 22878361
[TBL] [Abstract][Full Text] [Related]
14. Postnatal dexamethasone treatment and retinopathy of prematurity in very-low-birth-weight neonates.
Cuculich PS; DeLozier KA; Mellen BG; Shenai JP
Biol Neonate; 2001 Jan; 79(1):9-14. PubMed ID: 11150824
[TBL] [Abstract][Full Text] [Related]
15. Growth and growth factors in premature infants receiving dexamethasone for bronchopulmonary dysplasia.
Skinner AM; Battin M; Solimano A; Daaboul J; Kitson HF
Am J Perinatol; 1997 Oct; 14(9):539-46. PubMed ID: 9394163
[TBL] [Abstract][Full Text] [Related]
16. Delayed Dexamethasone Therapy and Neurodevelopmental Outcomes in Preterm Infants with Bronchopulmonary Dysplasia.
Lim G; Lee BS; Choi YS; Park HW; Chung ML; Choi HJ; Kim EA; Kim KS
Pediatr Neonatol; 2015 Aug; 56(4):261-7. PubMed ID: 25649722
[TBL] [Abstract][Full Text] [Related]
17. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
Oakes ND; Thalén PG; Jacinto SM; Ljung B
Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
[TBL] [Abstract][Full Text] [Related]
18. Vitamin A status and postnatal dexamethasone treatment in bronchopulmonary dysplasia.
Shenai JP; Mellen BG; Chytil F
Pediatrics; 2000 Sep; 106(3):547-53. PubMed ID: 10969101
[TBL] [Abstract][Full Text] [Related]
19. Incidence of hypertriglyceridemia in critically ill neonates receiving lipid injectable emulsions in glass versus plastic containers: a retrospective analysis.
Martin CR; Dumas GJ; Shoaie C; Zheng Z; Mackinnon B; Al-Aweel I; Bistrian BR; Pursley DM; Driscoll DF
J Pediatr; 2008 Feb; 152(2):232-6. PubMed ID: 18206695
[TBL] [Abstract][Full Text] [Related]
20. Plasma lipid levels in preterm neonates receiving parenteral fat emulsions.
Hilliard JL; Shannon DL; Hunter MA; Brans YW
Arch Dis Child; 1983 Jan; 58(1):29-33. PubMed ID: 6402989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
